Dr. Wilhelm, DMD MSD, and Staff Receives Exclusive ACE Certification To Provide Patients with Expert Periodontal Disease Diagnosis and Treatment

Share Article

Dr. Wilhelm, DMD MSD, and his entire staff recently received ARESTIN® Certified Expert (ACE™) certification after completing comprehensive training on the diagnosis and treatment of periodontal disease.

Dr. Wilhelm, DMD MSD, and his entire staff recently received ARESTIN® Certified Expert (ACE™) certification.

I felt it was important that my entire staff went through the periodontal disease diagnosis and treatment training program to ensure we can provide our patients with the highest standard of care available.

Dr. Wilhelm, DMD MSD, and his entire staff recently received ARESTIN® Certified Expert (ACE™) certification after completing comprehensive training on the diagnosis and treatment of periodontal disease.

The exclusive ACE™ certification is important because periodontal disease is the most common chronic bacterial infection in adults, affecting 35.7 million Americans, and is the leading cause of adult tooth loss.2 In addition, the Surgeon General has issued a warning3 regarding the possible relationship between periodontal disease and a variety of medical conditions, including cardiovascular disease, diabetes, and osteoporosis.

"Knowing the negative impact periodontal disease can have on an individual's oral health and general health prompted me to enroll in the ACE™ certification training," said Dr. Wilhelm "I felt it was important that my entire staff went through the periodontal disease diagnosis and treatment training program to ensure we can provide our patients with the highest standard of care available."

In order to earn ACE™ certification, Dr. Wilhelm and his staff was trained and tested in the following areas: accurate diagnosis of periodontal disease, effective treatment protocol, accurate insurance coding, the benefits of using LAAs, staff and patient education, encouraging patient compliance, patient monitoring, and the possible systemic health risks of untreated periodontal disease.

ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg is a locally administered antibiotic (LAA) manufactured by OraPharma, Inc. to treat periodontal disease. Clinical studies have proven that ARESTIN® used as an adjunct to scaling and root planing (SRP) is more effective than SRP alone in eliminating periodontal pathogens.4 SRP is a manual procedure that is performed by a dentist or registered dental hygienist, whereby bacterial pathogens residing in the plaque and tartar are removed from below the gum line while smoothing the tooth's root surfaces to promote healing and prevent plaque from again taking hold.

About Dr. Mark Wilhelm, DMD MSD:
Dr. Wilhelm has been in private practice in St. Paul and now Woodbury, since 1990,where he is focused on cosmetic dentistry, sedation dentistry, advanced restorative and implant dentistry. Over the years, he has integrated technology into his practice, allowing him to treat his patients using minimally invasive dentistry. For more information about Dr Wilhelm's practice, visit his Web site at http://www.imagineyoursmile.com.

He is recognized as a Diplomate of the International Congress of Oral Implantologists and is an active member of the American College of Prosthodontists, American Dental Association, and Minnesota Dental Association. He is also an associate professor at the University of Minnesota School of Dentistry and a consultant with the Cleft Lip and Palate clinic. An author, mentor and frequent speaker to dentists and the public on techniques that enhance oral health, Dr Wilhelm continually travels the world to improve his understanding and skill level in implant, restorative, and esthetic dentistry.

1. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and
older in the United States, 1988-1994. J Periodontol 1999;70:13-29.
2. Lewis C. Fighting gum disease: how to keep your teeth. FDA Consum 2002;36:16-22.
3. US Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health; 2000. Goodson JM. Antimicrobial Efficacy of Arestin in Periodontitis Therapy. Presented at the 35th Annual Meeting of the American Association for Dental Research; March 8-11, 2006; Orlando, FL.

The decision to administer ARESTIN® is made solely by the healthcare professional.

ARESTIN® is a registered trademark of OraPharma, Inc./ACE™ is a trademark of OraPharma, Inc./© OraPharma, Inc. 2007 A-549-07 6/07

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dr. Mark Wilhelm, DMD MSD
Visit website